Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

ReNeuron chooses Angel for GMP stem cell production
August 2011
SHARING OPTIONS:

GUILDFORD, U.K.ReNeuron Group PLC recently announced the establishment of a deal with biopharmaceutical contract manufacturer organization (CMO) Angel Biotechnology Holdings PLC to outsource stem cell GMP production services to the CMO. Angel Biotechnology will provide manufacturing services to support ReNeuron's ReN001 stem cell therapy for stroke through mid-2012. The program consists of the GMP manufacture and associated work for future cohorts of patients in ReNeuron's PISCES clinical trial, an ongoing Phase I study of ReN001 as a stem cell therapy for disability in patients who have suffered an ischemic stroke. No financial details about the contract were disclosed. Gordon Sheriff, chief operating officer at Angel Biotechnology, said in a press release that they are "very pleased that ReNeuron's PISCES clinical trial in stroke is proceeding well and look forward to continuing to provide our highest-quality manufacturing support for this clinical trial."


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.